Editorial

The Atrioventricular Node Revisited

Register or Login to View PDF Permissions
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
Information image
Average (ratings)
No ratings
Your rating

Received:

Accepted:

Published online:

Disclosure: DGK is editor-in-chief of Arrhythmia & Electrophysiology Review; this did not influence acceptance.

Correspondence: Demos Katritsis, Hygeia Hospital, 4 Erythrou Stavrou St, Athens 15123, Greece. E: dkatrits@dgkatritsis.gr

Copyright:

© The Author(s). This work is open access and is licensed under CC-BY-NC 4.0. Users may copy, redistribute and make derivative works for non-commercial purposes, provided the original work is cited correctly.

In a previous publication with Bob Anderson, we compared the nature of the atrioventricular (AV) node (almost 120 years after Tawara’s original description in 1906), with the riddle of Sphynx.1 In the great Sophoclean tragedy, the denouement of the riddle of Sphinx by mortal Oedipus was initially perceived by the Athenians as a form of hubris against the gods by a human, in the light of its insurmountable difficulty. We thought then that the accumulation of recent anatomical and electrophysiological evidence enabled us to provide the rationale for solving the nodal riddle without committing scientific hubris. However, myths and fiction still prevail in cardiology literature about the nature and conduction properties of the node both during sinus rhythm and tachycardia states.

The Atrioventricular Node does not Possess ‘Fast’ and ‘Slow’ Pathways

In the human heart, the transition between the atrial and ventricular components is found at the site where the apex of the inferior pyramidal space overlaps the inferior extent of the inferoseptal recess of the left ventricle.2 This arrangement permits the inferior atrial inputs of the AV node, formed as inferior extensions within the vestibules of the tricuspid and mitral valves, to merge, producing the compact AV node at the apex of the inferior pyramidal space.3,4 The right inferior extension is a combination of AV canal myocardium and the atrial component of the primary ring. Hence, it retains its ‘specialised’ histological characteristics, and is capable of both fast and slow conduction. The leftward extension is exclusively AV canal myocardium, and is not ‘specialised’ when assessed using standard histological stains, and is capable of only slow conduction.5 This notion is also supported by connexin genotyping studies that have shown that poor gap junction connectivity, due to differential expression of connexin isoforms, can result in substantially different conduction properties.6,7 Thus, both extensions may act as the substrate of a ‘slow’ pathway for a re-entry circuit.8–10

The cardiomyocytes of the central or right and left parts of the septum also provide inputs to the AV node before the node becomes insulated as the non-branching bundle (bundle of His; Figure 1). These atrial-nodal connections, such as the so-called ‘last connection’, are composed of ordinary working myocardium possessing atrial, or fast, conduction properties.11 Preferential conduction to the node through these inputs provides the anatomical substrate of a ‘fast’ pathway. Thus, the atrial inputs to the node possess fast and slow conduction properties, not the node itself.

Figure 1: Serial Histological Sections Taken from a Neonate who Died at the Age of 6 Months

Article image

There is no Dual Atrioventricular Nodal Conduction

Studies have provided evidence on the conduction velocity in the area of the AV node and its inferior extension, calculating it to between 0.02 and 0.1 m/s in perfused canine and rabbit hearts.12–14 In the human heart, mathematical modelling of the conduction velocity in these areas has provided a value of 0.04 m/s.15 For comparison, in the atrium, conduction velocities range from 0.5 to 0.8 m/s,15–17 and in the His bundle 1.2–1.7 m/s.15,18 Thus, slow, decremental conduction is a characteristic of the compact node itself and, perhaps, also of the inferior extensions, particularly the left. During sinus rhythm, or during ectopic or paced atrial rhythms, conduction to the node occurs through the fast-conducting, septal inputs (Figure 2). When the rates are fast enough to reach the refractoriness of these inputs, conduction travels through the inferior nodal extensions and jumps may be seen. All this is due to the difference in the conduction properties of atrial inputs; dual conduction of the AV node is a misnomer in scientific terms.

Figure 2: Proposed Model for Atrioventricular Axis Conduction During Sinus Rhythm as Mapped on the Right Septum

Article image

No Nodal Re-entry Exists

The AV node is a small structure, of an average length of 5 mm and width of 3 mm.19,20 Mathematical modelling has allowed calculation of the length of the slow and fast pathways in typical AV nodal re-entry tachycardia, and indicates that the tachycardia uses a circuit from the AV node to the septal isthmus of an average size of 5–6 cm, confined within the pyramid of Koch.21,22 These results have been verified by measurements of the relevant areas in histology specimens of human hearts.22 Thus, the tachycardia circuit is not contained within the AV node. It is junctional rather than nodal re-entrant tachycardia.

We do Not, Usually, Ablate the Node for Interruption of Atrioventricular Conduction

AV junctional ablation is perceived as implementing damage to the AV conduction axis by delivering radio frequency at a site where it is possible to record an atrial deflection with the earliest His bundle potential, followed by the ventricular deflection from the right or left septum.23–29 Alternatively, alleged ‘specific’ ablation is achieved by simply targeting the site with the most prominent His bundle potential.27,30–42 In patients with AF, in particular, the recording of a His bundle potential is the only feature guiding the chosen site of ablation. Both approaches, however, are unlikely to deliver lesions at the location of the AV node or its extensions.11,29 Since mapping of the AV node is not yet possible in humans, specific ablation of the AV node can only be achieved by using specific anatomical landmarks in a dedicated procedure.43

References

  1. Katritsis DG, Anderson RH. New insights into the mechanisms of fast and slow conduction in the atrioventricular node. Heart Rhythm 2023;20:627–30. 
    Crossref | PubMed
  2. Macias Y, de Almeida MC, Tretter JT, et al. Miniseries 1-Part II: the comparative anatomy of the atrioventricular conduction axis. Europace 2022;24:443–54. 
    Crossref | PubMed
  3. Inoue S, Becker AE. Posterior extensions of the human compact atrioventricular node: a neglected anatomic feature of potential clinical significance. Circulation 1998;97:188–93. 
    Crossref | PubMed
  4. Matteucci A, Pandozi C, Russo M, et al. Relevance of anatomical significance of AV nodal structures within Koch’s triangle and pyramid. J Cardiovasc Dev Dis 2024;11:323. 
    Crossref | PubMed
  5. Anderson RH, Sanchez-Quintana D, Mori S, et al. Unusual variants of pre-excitation: from anatomy to ablation: Part I-Understanding the anatomy of the variants of ventricular pre-excitation. J Cardiovasc Electrophysiol 2019;30:2170–80. 
    Crossref | PubMed
  6. George SA, Faye NR, Murillo-Berlioz A, et al. At the atrioventricular crossroads: dual pathway electrophysiology in the atrioventricular node and its underlying heterogeneities. Arrhythm Electrophysiol Rev 2017;6:179–85. 
    Crossref | PubMed
  7. Katritsis DG, Efimov IR. Cardiac connexin genotyping for identification of the circuit of atrioventricular nodal re-entrant tachycardia. Europace 2019;21:190–1. 
    Crossref | PubMed
  8. Katritsis DG, Becker AE, Ellenbogen KA, et al. Effect of slow pathway ablation in atrioventricular nodal reentrant tachycardia on the electrophysiologic characteristics of the inferior atrial inputs to the human atrioventricular node. Am J Cardiol 2006;97:860–5. 
    Crossref | PubMed
  9. Abu-Alrub S, Florian F, Boudias A, et al. Slow/fast atrioventricular nodal reentrant tachycardia catheter ablation guided by atrial resetting: the new insight. Heart Rhythm 2025:S1547-5271(25)02174-5. 
    Crossref | PubMed
  10. Park S, Park JW, Kim S, et al. Upper common pathway analysis using late atrial premature depolarization in atrioventricular nodal reentry tachycardia. Heart Rhythm 2024;21:1729–34. 
    Crossref | PubMed
  11. Anderson RH, Sanchez-Quintana D, Mori S, et al. Re-evaluation of the structure of the atrioventricular node and its connections with the atrium. Europace 2020;22:821–30. 
    Crossref | PubMed
  12. Efimov IR, Nikolski VP, Rothenberg F, et al. Structure-function relationship in the AV junction. Anat Rec A Discov Mol Cell Evol Biol 2004;280:952–65. 
    Crossref | PubMed
  13. Choi BR, Salama G. Optical mapping of atrioventricular node reveals a conduction barrier between atrial and nodal cells. Am J Physiol 1998;274:H829–45. 
    Crossref | PubMed
  14. Temple IP, Inada S, Dobrzynski H, Boyett MR. Connexins and the atrioventricular node. Heart Rhythm 2013;10:297–304. 
    Crossref | PubMed
  15. Greener ID, Monfredi O, Inada S, et al. Molecular architecture of the human specialised atrioventricular conduction axis. J Mol Cell Cardiol 2011;50:642–51. 
    Crossref | PubMed
  16. Zheng Y, Xia Y, Carlson J, et al. Atrial average conduction velocity in patients with and without paroxysmal atrial fibrillation. Clin Physiol Funct Imaging 2017;37:596–601. 
    Crossref | PubMed
  17. de Groot JR, Veenstra T, Verkerk AO, et al. Conduction slowing by the gap junctional uncoupler carbenoxolone. Cardiovasc Res 2003;60:288–97. 
    Crossref | PubMed
  18. Kupersmith J, Krongrad E, Waldo AL. Conduction intervals and conduction velocity in the human cardiac conduction system. Studies during open-heart surgery. Circulation 1973;47:776–85. 
    Crossref | PubMed
  19. Anderson RH, Mori S, Spicer DE, et al. The anatomy, development, and evolution of the atrioventricular conduction axis. J Cardiovasc Dev Dis 2018;5:44. 
    Crossref | PubMed
  20. Tretter JT, Koneru JN, Spicer DE, et al. A new dimension in cardiac imaging: three-dimensional exploration of the atrioventricular conduction axis with hierarchical phase-contrast tomography. Heart Rhythm 2024;21:2388–96. 
    Crossref | PubMed
  21. Katritsis DG, al, Marine JE, Katritsis G, et al. Spatial characterization of the tachycardia circuit of atrioventricular nodal reentrant tachycardia. Europace 2021;23:1596–602. 
    Crossref | PubMed
  22. Katritsis D, Tretter JT, Marine JE, et al. Quantitative assessment of the fast pathway in atrioventricular nodal reentrant tachycardia. J Interv Card Electrophysiol 2023;66:991–6. 
    Crossref | PubMed
  23. Kay GN, Ellenbogen KA, Giudici M, et al. The Ablate and Pace Trial: a prospective study of catheter ablation of the AV conduction system and permanent pacemaker implantation for treatment of atrial fibrillation. APT Investigators. J Interv Card Electrophysiol 1998;2:121–35. 
    Crossref | PubMed
  24. Yeung-Lai-Wah JA, Alison JF, Lonergan L, et al. High success rate of atrioventricular node ablation with radiofrequency energy. J Am Coll Cardiol 1991;18:1753–8. 
    Crossref | PubMed
  25. Jackman WM, Wang XZ, Friday KJ, et al. Catheter ablation of atrioventricular junction using radiofrequency current in 17 patients. Comparison of standard and large-tip catheter electrodes. Circulation 1991;83:1562–76. 
    Crossref | PubMed
  26. Natale A, Zimerman L, Tomassoni G, et al. Impact on ventricular function and quality of life of transcatheter ablation of the atrioventricular junction in chronic atrial fibrillation with a normal ventricular response. Am J Cardiol 1996;78:1431–3. 
    Crossref | PubMed
  27. Twidale N, McDonald T, Nave K, Seal A. Comparison of the effects of AV nodal ablation versus AV nodal modification in patients with congestive heart failure and uncontrolled atrial fibrillation. Pacing Clin Electrophysiol 1998;21:641–51. 
    Crossref | PubMed
  28. Vijayaraman P, Subzposh FA, Naperkowski A. Atrioventricular node ablation and His bundle pacing. Europace 2017;19(Suppl 4):iv10–6. 
    Crossref | PubMed
  29. Rizzo S, Corrado A, De Gaspari M, et al. Transcatheter ablation of the atrioventricular junction in refractory atrial fibrillation: a clinicopathological study. Int J Cardiol 2021;329:99–104. 
    Crossref | PubMed
  30. Buys EM, van Hemel NM, Kelder JC, et al. Exercise capacity after His bundle ablation and rate response ventricular pacing for drug refractory chronic atrial fibrillation. Heart 1997;77:238–41. 
    Crossref | PubMed
  31. Souza O, Gursoy S, Simonis F, et al. Right-sided versus left-sided radiofrequency ablation of the His bundle. Pacing Clin Electrophysiol 1992;15:1454–9. 
    Crossref | PubMed
  32. Urcelay G, Dick M, 2nd, Bove EL, et al. Intraoperative mapping and radiofrequency ablation of the His bundle in a patient with complex congenital heart disease and intractable atrial arrhythmias following the Fontan operation. Pacing Clin Electrophysiol 1993;16:1437–40. 
    Crossref | PubMed
  33. Poquet F, Clémenty J, Gencel L, Haissaguerre M. Survival after His bundle ablation for supraventricular arrhythmia. A 10-year experience in 317 consecutive patients [in French]. Arch Mal Coeur Vaiss 1995;88:1593–600.
    PubMed
  34. Fenelon G, Goethals M, Brugada P. Two hearts beating as one: radiofrequency ablation of the His bundle in a heterotopic heart transplant patient. Pacing Clin Electrophysiol 1996;19:374–5. 
    Crossref | PubMed
  35. Vaksmann G, Lacroix D, Klug D. Radiofrequency ablation of the His bundle for malignant atrial flutter after Mustard procedure for transposition of the great arteries. Am J Cardiol 1996;77:669–70. 
    Crossref | PubMed
  36. Buys EM, van Hemel NM, Jessurun ER, et al. VDDR pacing after His-bundle ablation for paroxysmal atrial fibrillation: a pilot study. Pacing Clin Electrophysiol 1998;21:1869–72. 
    Crossref | PubMed
  37. Edner M, Caidahl K, Bergfeldt L, et al. Prospective study of left ventricular function after radiofrequency ablation of atrioventricular junction in patients with atrial fibrillation. Br Heart J 1995;74:261–7. 
    Crossref | PubMed
  38. Trohman RG, Simmons TW, Moore SL, et al. Catheter ablation of the atrioventricular junction using radiofrequency energy and a bilateral cardiac approach. Am J Cardiol 1992;70:1438–43. 
    Crossref | PubMed
  39. Heinz G, Siostrzonek P, Kreiner G, Gossinger H. Improvement in left ventricular systolic function after successful radiofrequency His bundle ablation for drug refractory, chronic atrial fibrillation and recurrent atrial flutter. Am J Cardiol 1992;69:489–92. 
    Crossref | PubMed
  40. Jensen SM, Bergfeldt L, Rosenqvist M. Long-term follow-up of patients treated by radiofrequency ablation of the atrioventricular junction. Pacing Clin Electrophysiol 1995;18:1609–14. 
    Crossref | PubMed
  41. Nam MCY, O’Sullivan P, Tonchev I, et al. His bundle combined with deep septal left bundle branch area pacing for atrial fibrillation prior to atrioventricular node ablation. J Arrhythm 2023;39:27–33. 
    Crossref | PubMed
  42. Morady F, Calkins H, Langberg JJ, et al. A prospective randomized comparison of direct current and radiofrequency ablation of the atrioventricular junction. J Am Coll Cardiol 1993;21:102–9. 
    Crossref | PubMed
  43. Katritsis DG, Siontis KC, Agarwal S, et al. Anatomical ablation of the atrioventricular node. Arrhythm Electrophysiol Rev 2024;13:e12. 
    Crossref | PubMed